We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 30.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 345.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Jul 2009 14:38

RNS Number : 0319V
Cropper(James) PLC
02 July 2009
 



Date: Thursday, 2 July 2009

JAMES CROPPER PLC

DIRECTOR SHAREHOLDING

Long Term Incentive Plan Award

On 23 June 2009, under the terms of The James Cropper PLC 2008 Long Term Incentive Plan, the following executive directors were granted awards by James Cropper EBT Limited, trustees of the James Cropper Employee Trust.

Name

Shares under Conditional Award

Percentage of Issued Share Capital

A. I. Lewis

25,000

0.30%

J.M.Denman

20,000

0.23%

N.A.Read

20,000

0.23%

P.J.Willink

20,000

0.23%

G.T.Quayle

20,000

0.23%

The number of shares referred to is the maximum available and the conditions on which the awarded shares will vest are as follows:

• if the Company's adjusted earnings per share for the financial period ending 31 March 2012 exceeds its adjusted earnings per share for the financial period ending 31 March 2009 by the increase in the retail prices index over the three year period commencing with the date of grant of the awards plus 2.5% per year (the 'minimum target'), the awards will vest as to 10%;

• if the Company's adjusted earnings per share for the financial period ending 31 March 2012 exceeds its adjusted earnings per share for the financial period ending 31 March 2009 by the increase in the retail prices index over the three year period commencing with the date of grant of the awards plus 10% per year (the 'maximum target'), the awards that will vest in full; and

• if the Company's adjusted earnings per share for the financial period ending 31 March 2012 exceeds its adjusted earnings per share for the financial period ending 31 March 2009 by more than the minimum target but by less than the maximum target, the proportion of the awards that will vest will increase from 10% to 100% on a straight line basis.

The participating directors will, following the end of the performance period, be notified as to the extent to which the performance conditions have been met and their awards have vested. They will then, provided that that they continue to remain directors or employees of the Company, have up to six months following 23 June 2012 (the third anniversary of the date on which the awards were granted) in which to secure the release of the ordinary shares.

Enquiries:

John Denman, Group Finance Director

James Cropper PLC

Tel: 01539 722002 

www.cropper.com

Andrew Kitchingman, Corporate Finance

Brewin Dolphin Investment Banking

Tel: 0845 270 8610

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFVVDDIFIIA
Date   Source Headline
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.